Article
FAM111B, LAG3, and FGL1, A Three-Gene Signature as a Predictive Biomarker for Immunotherapy Response in Bladder Urothelial Carcinoma
2026-08-18
Abstract excerpt
<title>Abstract</title> <p>Background Immunotherapy has markedly extended survival in some patients with bladder urothelial carcinoma (BLCA). However, only a subset of patients experience sustained clinical benefit. Thus, the identification of reliable biomarkers for predicting immunotherapy response are required. Methods Transcriptomic and clinical data from the IMvigor210 cohort treated with anti–PD-L1 therap...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bcbcaef5-cad7-52c4-bad3-e1699656330d
- DOI
- 10.21203/rs.3.rs-9483128/v1
